PCV30 ECONOMIC EVALUATION OF THREE MARKET LEADING HMG-CO-A REDUCTASE INHIBITORS
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)60944-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)60944-8/fulltext
Section Title :
Section Order :
132
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60944-8&doi=10.1016/S1098-3015(10)60944-8